Series A · Biotech · Leuven, Belgium · Founded 2019 · 2–10 employees
Rewind Therapeutics is a Leuven-based biotech company developing first-in-class small-molecule remyelination therapies for major neurological diseases such as multiple sclerosis by harnessing the body’s natural myelin repair processes; for biotech researchers and translational scientists this means contributing to next-generation therapeutic discovery, working with world-class academic and industry collaborators, and advancing compounds from discovery into early clinical development with strong life-science investor backing.
No open roles listed right now.